Hap Trading, LLC Oncternal Therapeutics, Inc. Call Options Transaction History

Hap Trading, LLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2022 Aug 12, 2022	SELL	$0.7 - $1.56 $350 - $780	-500 Reduced 4.46%	10,700 $0
Q1 2022 May 12, 2022	BUY	$1.37 - $2.43 $15,344 - $27,216	11,200 New	11,200 $1,000
Q4 2021 Feb 14, 2022	SELL	$2.27 - $4.39 $273,081 - $528,117	-120,300 Closed	0 $0
Q3 2021 Nov 10, 2021	BUY	$3.37 - $4.76 $73,803 - $104,244	21,900 Added 22.26%	120,300 $17,000
Q2 2021 Aug 11, 2021	BUY	$4.75 - $9.39 $417,050 - $824,442	87,800 Added 828.3%	98,400 $92,000
Q1 2021 May 14, 2021	BUY	$4.59 - $9.04 $48,654 - $95,823	10,600 New	10,600 $20,000

362K

Ticker ONCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,517,200
Market Cap $29.4M
Description
Oncternal Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of oncology therapies for cancers with critical unmet medical needs. The company's clinical pipeline includes zilovertamab, a humanized monoclonal antibody that binds to receptor-tyrosine kinase-like Orphan Receptor 1 (ROR1); and ONCT-216, a smal...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.